173 related articles for article (PubMed ID: 26709138)
1. Calcitriol and 20(S)-protopanaxadiol synergistically inhibit growth and induce apoptosis in human prostate cancer cells.
Ben-Eltriki M; Deb S; Adomat H; Tomlinson Guns ES
J Steroid Biochem Mol Biol; 2016 Apr; 158():207-219. PubMed ID: 26709138
[TBL] [Abstract][Full Text] [Related]
2. 1α,25-Dihydroxyvitamin D
Ben-Eltriki M; Deb S; Guns EST
J Steroid Biochem Mol Biol; 2021 May; 209():105828. PubMed ID: 33493594
[TBL] [Abstract][Full Text] [Related]
3. Anti-Tumor Effects of Ginsenoside 20(S)-Protopanaxadiol and 1,25-Dihydroxyvitamin D3 Combination in Castration Resistant Prostate Cancer.
Ben-Eltriki M; Deb S; Shankar G; Meckling G; Hassona M; Yamazaki T; Fazli L; Chin MY; Tomlinson Guns ES
Medicines (Basel); 2021 Jun; 8(6):. PubMed ID: 34199743
[TBL] [Abstract][Full Text] [Related]
4. A novel oral dosage formulation of the ginsenoside aglycone protopanaxadiol exhibits therapeutic activity against a hormone-insensitive model of prostate cancer.
Musende AG; Eberding A; Wood CA; Adomat H; Fazli L; Hurtado-Coll A; Jia W; Bally MB; Tomlinson Guns ES
Anticancer Drugs; 2012 Jun; 23(5):543-52. PubMed ID: 22481061
[TBL] [Abstract][Full Text] [Related]
5. Rh2 or its aglycone aPPD in combination with docetaxel for treatment of prostate cancer.
Musende AG; Eberding A; Jia W; Ramsay E; Bally MB; Guns ET
Prostate; 2010 Sep; 70(13):1437-47. PubMed ID: 20687217
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic interaction of calcitriol with 20(S)-protopanaxadiol in mice: Determined by LC/MS analysis.
Ben-Eltriki M; Hassona M; Meckling G; Adomat H; Deb S; Tomlinson Guns ES
Eur J Pharm Sci; 2019 Mar; 130():173-180. PubMed ID: 30654110
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and pharmacodynamics of Rh2 and aPPD ginsenosides in prostate cancer: a drug interaction perspective.
Ben-Eltriki M; Shankar G; Tomlinson Guns ES; Deb S
Cancer Chemother Pharmacol; 2023 Dec; 92(6):419-437. PubMed ID: 37709921
[TBL] [Abstract][Full Text] [Related]
8. Ginsenoside-mediated blockade of 1α,25-dihydroxyvitamin D3 inactivation in human liver and intestine in vitro.
Deb S; Chin MY; Adomat H; Guns ES
J Steroid Biochem Mol Biol; 2014 May; 141():94-103. PubMed ID: 24486455
[TBL] [Abstract][Full Text] [Related]
9. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.
Murthy S; Agoulnik IU; Weigel NL
Prostate; 2005 Sep; 64(4):362-72. PubMed ID: 15754350
[TBL] [Abstract][Full Text] [Related]
10. 20(S)-protopanaxadiol regio-selectively targets androgen receptor: anticancer effects in castration-resistant prostate tumors.
Ben-Eltriki M; Deb S; Hassona M; Meckling G; Fazli L; Chin MY; Lallous N; Yamazaki T; Jia W; Rennie PS; Cherkasov A; Tomlinson Guns ES
Oncotarget; 2018 Apr; 9(30):20965-20978. PubMed ID: 29765513
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of proliferation and induction of apoptosis by 25-hydroxyvitamin D3-3beta-(2)-Bromoacetate, a nontoxic and vitamin D receptor-alkylating analog of 25-hydroxyvitamin D3 in prostate cancer cells.
Swamy N; Chen TC; Peleg S; Dhawan P; Christakos S; Stewart LV; Weigel NL; Mehta RG; Holick MF; Ray R
Clin Cancer Res; 2004 Dec; 10(23):8018-27. PubMed ID: 15585637
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer.
Thakkar A; Wang B; Picon-Ruiz M; Buchwald P; Ince TA
Breast Cancer Res Treat; 2016 May; 157(1):77-90. PubMed ID: 27120467
[TBL] [Abstract][Full Text] [Related]
13. Synergistic anticancer effects of ruxolitinib and calcitriol in estrogen receptor‑positive, human epidermal growth factor receptor 2‑positive breast cancer cells.
Lim ST; Jeon YW; Gwak H; Kim SY; Suh YJ
Mol Med Rep; 2018 Apr; 17(4):5581-5588. PubMed ID: 29436642
[TBL] [Abstract][Full Text] [Related]
14. Combination of calcitriol and dietary soy exhibits enhanced anticancer activity and increased hypercalcemic toxicity in a mouse xenograft model of prostate cancer.
Wang JY; Swami S; Krishnan AV; Feldman D
Prostate; 2012 Nov; 72(15):1628-37. PubMed ID: 22457201
[TBL] [Abstract][Full Text] [Related]
15. Antiproliferative effect of 1alpha,25-dihydroxyvitamin D3 in human prostate cancer cell line LNCaP involves reduction of cyclin-dependent kinase 2 activity and persistent G1 accumulation.
Zhuang SH; Burnstein KL
Endocrinology; 1998 Mar; 139(3):1197-207. PubMed ID: 9492054
[TBL] [Abstract][Full Text] [Related]
16. Astemizole synergizes calcitriol antiproliferative activity by inhibiting CYP24A1 and upregulating VDR: a novel approach for breast cancer therapy.
García-Quiroz J; García-Becerra R; Barrera D; Santos N; Avila E; Ordaz-Rosado D; Rivas-Suárez M; Halhali A; Rodríguez P; Gamboa-Domínguez A; Medina-Franco H; Camacho J; Larrea F; Díaz L
PLoS One; 2012; 7(9):e45063. PubMed ID: 22984610
[TBL] [Abstract][Full Text] [Related]
17. 20S-protopanaxadiol inhibits P-glycoprotein in multidrug resistant cancer cells.
Zhao Y; Bu L; Yan H; Jia W
Planta Med; 2009 Aug; 75(10):1124-8. PubMed ID: 19291609
[TBL] [Abstract][Full Text] [Related]
18. Combination of vitamin E and selenium causes an induction of apoptosis of human prostate cancer cells by enhancing Bax/Bcl-2 ratio.
Reagan-Shaw S; Nihal M; Ahsan H; Mukhtar H; Ahmad N
Prostate; 2008 Nov; 68(15):1624-34. PubMed ID: 18668529
[TBL] [Abstract][Full Text] [Related]
19. 1alpha,25-dihydroxyvitamin D3 inhibits prostate cancer cell growth by androgen-dependent and androgen-independent mechanisms.
Zhao XY; Peehl DM; Navone NM; Feldman D
Endocrinology; 2000 Jul; 141(7):2548-56. PubMed ID: 10875257
[TBL] [Abstract][Full Text] [Related]
20. 20(S)-25-methoxyl-dammarane-3beta, 12beta, 20-triol, a novel natural product for prostate cancer therapy: activity in vitro and in vivo and mechanisms of action.
Wang W; Wang H; Rayburn ER; Zhao Y; Hill DL; Zhang R
Br J Cancer; 2008 Feb; 98(4):792-802. PubMed ID: 18253123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
